FIELD: medicine, ophthalmology.
SUBSTANCE: it is necessary to apply autoplasma, moreover, 30 min before autoblood sampling a patient should be instillated per 0.5 ml 0.25%-derinate solution into each nostril, then due to centrifuging one should sediment cell suspension, and obtained autoplasma should be applied as instillations into conjunctival cavity for about 5-7 d after operations. The innovation provides efficient treatment of corneal complications due to optimal balance of regulatory derinate-induced cytokines in autoplasma introduced.
EFFECT: higher efficiency of therapy.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING CORNEAL COMPLICATIONS AFTER PHOTOREFRACTION KERATECTOMY | 2005 |
|
RU2288632C1 |
| METHOD OF TREATING CORNEAL EROSIONS AFTER EXCIMER-LASER PHOTO- REFRACTION KERATECTOMIA | 1997 |
|
RU2122386C1 |
| METHOD FOR PREDICTING CORNEAL SUBEPITHELIAL FIBROPLASIA DEVELOPMENT AFTER PHOTOREFRACTIVE EXCIMER LASER KERATECTOMY | 2005 |
|
RU2291429C1 |
| METHOD FOR PREVENTING SUBEPITHELIAL FIBROPLASIA FROM OCCURRING AFTER PHOTOREFRACTION KERATECTOMY | 2003 |
|
RU2272621C2 |
| METHOD FOR PHOTOREFRACTIVE CORNEAL ABLATION | 2014 |
|
RU2578388C1 |
| METHOD FOR AFTER-CORRECTING RESIDUAL MYOPIC AMETROPIA AFTER PREVIOUS KERATOREFRACTIVE OPERATIONS | 2022 |
|
RU2786592C1 |
| METHOD OF SURGICAL CORRECTION OF HYPERMETROPIA AND HYPERMETROPIC ASTIGMIA ON THIN CORNEA IN CHILDREN WITH ANISOMETROPIA | 2007 |
|
RU2363432C2 |
| METHOD FOR TREATING THE CASES OF KERATOCONE | 1999 |
|
RU2146119C1 |
| NSAIDS APPLICATION IN EXCIMER LASER CORNEAL SURGERY | 2015 |
|
RU2612810C2 |
| METHOD FOR TREATING THE CASES OF POST-INFLAMMATION BULLOUS KERATOPATHY | 2000 |
|
RU2165747C1 |
